Of note, we also show experimentally that SLF2 loss leads to impaired CHK1 activation in response to DNA damage stress in non‐hematopoietic cancer cells and thus provide a mechanistic framework and identify a molecular vulnerability for a highly conserved feature of aggressive cancers. Here, SLF2 is linked to cancer.